Script Writer: Duncan Campbell
Summary Writer: Duncan Campbell
Editor: James Edwards
Interviewee: Ibrahim Tohidi
James talks to Dr Ibrahim Tohidi about the management of febrile neutropaenia on the wards.
Dr Tohidi is a Haematology Advanced trainee at Royal Prince Alfred Hospital and Concord Hospital. He is a Clinical Associate Lecturer at the University of Sydney, and a member of the RACP Working party for the use of stem cells in cerebral palsy. He graduated from the University of Newcastle with Distinction, and has a special interest in cellular therapies and blood banking.
With Dr Ibrahim Tohidi, Advanced Trainee in Haematology at Royal Prince Alfred Hospital/Concord Hospital and Clinical Associate Lecturer at the University of Sydney, New South Wales, Australia
Neutropenic sepsis is a potentially fatal complication of anticancer treatment, with adult mortality rates ranging from 2-21%. Junior doctors are often called to see febrile oncology and haematology patients on the ward after hours, and it is important to know how to recognise a patient with febrile neutropaenia, and how to act.
What is the definition of febrile neutropaenia?
What is the cause of neutropaenia in oncology and haematology patients?
When does febrile neutropaenia most commonly present?
Case 1 – You are called by the nursing staff on the ward to see a patient who has developed their first fever 8 days after having received their first cycle of chemotherapy.
If you enjoyed listening to this week’s podcast feel free to let us know what you think by posting your comments or suggestions in the comments box below.
If you want to listen to this episode while not connected to WiFi or the internet, you can download it. To find out more go to Apple support (https://support.apple.com/en-us/HT201859)